首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Green Synthesized Montmorillonite/Carrageenan/Fe3O4 Nanocomposites for pH-Responsive Release of Protocatechuic Acid and Its Anticancer Activity
【2h】

Green Synthesized Montmorillonite/Carrageenan/Fe3O4 Nanocomposites for pH-Responsive Release of Protocatechuic Acid and Its Anticancer Activity

机译:绿色合成蒙脱石/鹿茸/ Fe3O4纳米复合材料用于PhOP响应Protocatechuic酸及其抗癌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Discovery of a novel anticancer drug delivery agent is important to replace conventional cancer therapies which are often accompanied by undesired side effects. This study demonstrated the synthesis of superparamagnetic magnetite nanocomposites (Fe O -NCs) using a green method. Montmorillonite (MMT) was used as matrix support, while Fe O nanoparticles (NPs) and carrageenan (CR) were used as filler and stabilizer, respectively. The combination of these materials resulted in a novel nanocomposite (MMT/CR/Fe O -NCs). A series of characterization experiments was conducted. The purity of MMT/CR/Fe O -NCs was confirmed by X-ray diffraction (XRD) analysis. High resolution transmission electron microscopy (HRTEM) analysis revealed the uniform and spherical shape of Fe O NPs with an average particle size of 9.3 ± 1.2 nm. Vibrating sample magnetometer (VSM) analysis showed an M value of 2.16 emu/g with negligible coercivity which confirmed the superparamagnetic properties. Protocatechuic acid (PCA) was loaded onto the MMT/CR/Fe O -NCs and a drug release study showed that 15% and 92% of PCA was released at pH 7.4 and 4.8, respectively. Cytotoxicity assays showed that both MMT/CR/Fe O -NCs and MMT/CR/Fe O -PCA effectively killed HCT116 which is a colorectal cancer cell line. Dose-dependent inhibition was seen and the killing was enhanced two-fold by the PCA-loaded NCs (IC –0.734 mg/mL) compared to the unloaded NCs (IC –1.5 mg/mL). This study highlights the potential use of MMT/CR/Fe O -NCs as a biologically active pH-responsive drug delivery agent. Further investigations are warranted to delineate the mechanism of cell entry and cancer cell killing as well as to improve the therapeutic potential of MMT/CR/Fe O -NCs.
机译:新型抗癌药物递送剂的发现对于取代常规伴随不希望的副作用的常规癌症疗法是重要的。本研究证明了使用绿色方法合成超顺磁磁铁矿纳米复合材料(Fe O-NCS)。 Montmorillonite(MMT)用作基质载体,而Fe O型纳米颗粒(NPS)和角叉菜胶(Cr)分别用作填料和稳定剂。这些材料的组合导致新型纳米复合物(MMT / Cr / Fe O-NCS)。进行了一系列表征实验。通过X射线衍射(XRD)分析证实了MMT / Cr / Fe O-NCS的纯度。高分辨率透射电子显微镜(HRTEM)分析显示Fe O NP的均匀和球形,平均粒度为9.3±1.2nm。振动样品磁力计(VSM)分析显示了M值为2.16 emu / g,其矫顽力可忽略不计,确认超顺磁性。将protocatechuic acid(pca)加载到MMT / Cr / Fe O-NCS上,药物释放研究表明,15%和92%的PCA分别在pH 7.4和4.8处释放。细胞毒性测定显示MMT / Cr / Fe O-NCS和MMT / Cr / Fe O-PCA有效地杀死了HCT116,其是结直肠癌细胞系。看到剂量依赖性抑制,与卸载的NCS(IC -1.5mg / ml)相比,通过PCA负载的NCS(IC-0.734mg / mL)增强了杀灭的杀伤。本研究突出显示MMT / Cr / Fe O-NCS作为生物活性pH响应药物递送剂的潜在使用。有权进一步调查来描绘细胞进入和癌细胞杀伤的机制,以及改善MMT / Cr / Fe O-Ncs的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号